Cambridge, United Kingdom

Oliver Gobold

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Linde Aktiengesellschaft. Active years: 2018.


% Patents Active = 50.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Oliver Gobold: Innovator in Flow Control Technology

Introduction

Oliver Gobold is a distinguished inventor based in Cambridge, GB. He has made significant contributions to the field of flow control technology, holding a total of 2 patents. His innovative designs focus on enhancing the efficiency and functionality of fluid control systems.

Latest Patents

Oliver Gobold's latest patents include a "Subframe for a Valve Body" and a "Flow Apparatus." The subframe invention provides a structural solution for valve bodies with multiple location surfaces, ensuring effective engagement between its components. The flow apparatus is designed for vessels storing fluid under pressure, featuring a flow control valve that optimizes electrical current supply to enhance battery life and reduce maintenance needs.

Career Highlights

Oliver is currently employed at Linde Aktiengesellschaft, a leading company in the industrial gases sector. His work at Linde has allowed him to apply his inventive skills to real-world applications, contributing to advancements in flow control technologies.

Collaborations

Throughout his career, Oliver has collaborated with notable colleagues, including Piers Lambert and George Gregory. These partnerships have fostered a creative environment that encourages innovation and the development of cutting-edge technologies.

Conclusion

Oliver Gobold's contributions to flow control technology exemplify his commitment to innovation and efficiency. His patents reflect a deep understanding of engineering principles and a dedication to improving industrial processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…